Zenas BioPharma (ZBIO) Change in Acquisitions & Divestments (2025 - 2026)

Zenas BioPharma (ZBIO) recorded quarterly Change in Acquisitions & Divestments of $108.1 million in Q1 2026, up 55.52% quarter-over-quarter from $69.5 million in Q4 2025, and up 740.98% on a YoY basis from $12.9 million in Q1 2025.

Zenas BioPharma (ZBIO) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

Zenas BioPharma's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $108.1 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments rose 740.98% year-over-year to $108.1 million; the TTM figure through Mar 2026 stood at $296.2 million (changed N/A YoY), while the FY2025 annual figure was $200.9 million, up 3248.12% from the prior year.
  • Change in Acquisitions & Divestments was $108.1 million for Q1 2026 at Zenas BioPharma, up from $69.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $108.1 million in Q1 2026 to a low of $12.9 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Zenas BioPharma 1.10 Bn 379.43 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 108.13 Mn
Mar 31, 2026 108.13 Mn
Dec 31, 2025 69.53 Mn
Dec 31, 2025 69.53 Mn
Sep 30, 2025 104.24 Mn
Sep 30, 2025 104.24 Mn
Jun 30, 2025 14.26 Mn
Jun 30, 2025 14.26 Mn
Mar 31, 2025 12.86 Mn
Mar 31, 2025 12.86 Mn